Take part in research
In this section, you will find a list of all clinical research studies currently being supported by our department.
Research studies by category (A-Z)
Anxiety and Depression
The GLAD Study is a project set up to explore risk factors in individuals who have experienced depression and/or anxiety, including those with a diagnosis of bipolar disorder, OCD, or related disorders, at any time in their lives.
It aims to better understand depression and anxiety in order to find and develop more effective treatments. The GLAD Study is also part of the NIHR BioResource, which is a library of information about people’s health aiming to support research in both physical and mental health.
To take part in this study, people must:
- Have experienced symptoms of anxiety and/or depression during your life
- Be aged 16 and above
- Live in the UK
The GLAD Study enrolment process consists of four steps:
- Register on the website www.gladstudy.org.uk and read the Information Sheet
- Provide consent (please put AWP as where you heard about the study)
- Complete a questionnaire
- Provide a saliva sample
AWP Research and Development contacts:
Alexandra Young (alexandra
This study will close on the 30th November 2024
Clinical depression can impact an individual’s mood and motivation to pursue goals and affects how rewarding they find them. Current first-line treatments, such as psychological therapies and antidepressants, haven’t always proven effective for a good proportion of people who might have Treatment Resistant Depression (TRD).
PAX-D study aims to use an already existing drug called pramipexole (which is currently being used for Parkinson's disease) that could prove effective treatment for TRD by impacting factors such as mood and motivation.
During the trial, one group of people will be taking pramipexole and the other group will be taking a placebo; a tablet that looks like pramipexole, but has no effect. At the end of the trial, we will compare the information collected on people taking pramipexole with that from people taking placebo.
To take part in this study, people must:
- Be aged 18 or above (male or female)
- Have a diagnosis of major depression (DSM-V)
- Be currently taking an antidepressant medication and willing to continue
- Have lacked response to at least two antidepressants at therapeutic doses
Further information:
PAX-D study website: https://paxd.web.ox.ac.uk/
AWP Research and Development contacts:
Alexandra Young (alexandra
Mashal Asif (mashal
This study will close on the 31st May 2024
Attention Deficit Hyperactivity Disorder (ADHD)
Background:
The ART-CARMA Study aims to find out more about the link between adult ADHD and cardiometabolic diseases (for example, obesity, type-2 diabetes and cardiovascular disease).
ART-CARMA aims to obtain real-world data from the patient’s daily life. This will be done by using ADHD Remote Technology monitoring from a smartphone app, as well as a wearable device. The main aim is to see to what extent ADHD medication and physical activity influence cardiometabolic risks in adults with ADHD.
The long-term goal is to use the data to improve the management of cardiometabolic disease in adults with ADHD, and to improve ADHD medication treatment adherence and the personalisation of treatment.
To take part in this study, people must:
- Have a diagnosis of ADHD
- Be aged 18-60 years old
- Be fluent in English
- Be willing and able to complete self-reported assessments via smartphone
- Be willing to use either own compatible Android phone or a study Android phone as only smartphone
- Be willing to wear the wearable device (EmbracePlus)
- Not be on ADHD medication at the time of recruitment
People would be unable to take part in this trial if they:
- Have psychosis, are currently experiencing a major depressive episode, mania, drug dependence in the last six months, or a major neurological disorder
- Have had recent contact with psychiatric acute care (admission, crisis team or liaison team (A&E) in the last six months
- Are pregnant
Additional information:
Individuals will be invited to take part in the study whilst on the ADHD waiting list for starting ADHD medication.
The study will last for one year. Taking part will involve completing questionnaires, using a smartphone app and wearing a device (EmbracePlus) to monitor sleep, physical activity, cardiovascular health, oxygen saturation and excitement vs stress.
Individuals will be paid £30 at the point of enrolling in the study, and a further £5 for every completed questionnaire (6 months and 12 months). Individuals will also be paid an additional £30 at the end of the study period (12 months).
AWP Research and Development Contacts:
Ali Young (alexandra
Thalia Pilcher (t
This study will close on the 31st March 2024
Autistic Spectrum
We are inviting adults who have a diagnosis of autism and experience anxiety to take part in a research study. The study is called STRATA (SerTRaline for AnxieTy in adults with a diagnosis of Autism). It has been co-produced with experienced clinicians, researchers, and autistic people to investigate the treatment of anxiety in adults with a diagnosis of autism. AWP is hosting this study but people can take part from anywhere in the UK.
You can learn more about what is involved in taking part by reading the participant information here.
Please read the information carefully and feel free to discuss it with family, friends, carers, or others if you wish.
To take part in this study, people must:
- be aged 18 years or over
- have a diagnosis of autism (including variations such as Asperger syndrome)
- experience anxiety for which you are willing to try treatment with medication
- be able to complete online or paper questionnaires about things such as your anxiety, other symptoms, and healthcare usage
- be able to provide informed consent to take part
How long does it take?
Participants will be enrolled to the study for up to 52 weeks (1 year), during which time they will be asked to take the study medication as directed, and complete four questionnaires (with their time reimbursed with a £10 voucher for each). In addition, there will be five brief safety check appointments to discuss how participants are getting on with the medication and carefully monitor any side effects. All study appointments can be done via video or phone call, or in person appointments (any travel expenses reimbursed) can be arranged according to participant preference.
What could I do next?
If you are interested in taking part in the study, please complete the online expression of interest form here
Alternatively, if you have any questions or would like further information or assistance, please contact the STRATA team by email: strata-takepart
AWP Research and Development contact:
This study will close on the 30th November 2023
ADEPT-2 is a Randomised Control Trial (RCT) for autistic adults, comparing Guided Self-Help with NHS support for depression.
Depression is a common mental health issue, related to lower quality of life. Research indicates that autistic people are more likely to experience depression than non-autistic people.
Effective treatment for depression includes a talking therapy called low intensity Cognitive Behavioural Therapy (CBT). This form of low intensity therapy is based on supporting the person receiving therapy to work through evidence-based information. This is called Guided Self-Help which has been shown to be useful in non-autistic adults, but it is not known whether it would also be useful for autistic adults.
The main goal of the ADEPT-2 study is to find out whether Guided Self-Help is helpful in reducing depression experienced by autistic adults.
The ADEPT-2 study also aims to determine whether Guided Self-Help would have a good cost-benefit for the NHS. In addition, the ADEPT-2 study aims to find out whether Guided Self-Help received by an autistic adult has impact on their family carers or supporters.
To take part in this study, people must:
- Be aged 18 and over
- Have received a diagnosis of autism spectrum disorder from a healthcare professional(s)
- Experience low mood or depression
- Be able to complete forms with questions either online or on paper
- Be able to give informed consent to take part
Further information:
If you decide to take part in the study, you will be randomly selected to receive either Guided Self-Help or NHS support for depression.
Guided Self-Help involves using a booklet, as well as attending 9 individual meetings with a coach to support use of the booklet. These meetings will be online. If you prefer to meet in person, the study team would be happy to discuss whether that would be possible.
NHS support for depression might include talking therapy, medication, self-coping strategies, and access to support groups.
The study will last for 52 weeks. Taking part will involve completing questionnaires at the start of the study, as well as 16 weeks, 32 weeks and 52 weeks later. You will be able to claim a £10 gift voucher for completing every set of questionnaires in the study. There will also be the option to be interviewed about your experience of the study at the end of the study.
Further information about the ADEPT-2 study can be found here.
ADEPT-2 study team contact:
If you wish to discuss the ADEPT-2 study or reasonable adjustments for taking part in the study, you can contact the ADEPT-2 study team directly by telephone (07855 973171) or email (adept-takepart
AWP Research and Development contact:
This study will close on the 1st January 2024
Bipolar and Psychosis
The Integrated Bipolar Parenting Intervention Trial (IBPI) team based at Lancaster University and Lancashire and South Cumbria NHS Foundation Trust are trying to find out whether providing online parenting support for parents with bipolar disorder (BD) helps parents to feel less stressed, have more confidence and experience fewer mood problems. The trial also aims to see whether use of the support leads their children to having fewer behavioural and emotional problems.
To take part in this trial, people must:
- Have a diagnosis of Bipolar Disorder (BD)
- Have a child aged 4-10 years old (with whom you have at least 10 hours of contact with a week)
- Have access to the internet
Further Information:
The Integrated Bipolar Parenting Intervention (IBPI) is an online tool that combines parenting support with helpful strategies for managing bipolar, and can be accessed on computers, mobile phones or tablets.
Individuals will be randomly allocated (50/50 chance) to receive the intervention or to receive what would be considered their usual care. Those that are allocated to receive usual care will be able to access the IBPI tool once they have completed the trial (after 48 weeks).
All activities related to the IBPI Trial will be done remotely / online.
If you are interested in finding out more and registering your interest, please visit: Bipolar-Parenting-Study | Lancaster University
IBPI Trial contact:
Telephone: 07507 856960
Email: ibpi
Website: www.lancs.ac.uk/spectrum/IBPI
This study will close on the 31st January 2025
The National Centre for Mental Health (NCMH) are researching the causes of mental health problems. Researchers are looking to gather information about people’s environment, lifestyle, and biology (including genes). Using this information, researchers hope to better understand why people experience mental health issues and how to develop better treatments.
To take part in this study, people must:
- Be 18 years old or over
- Have a diagnosis of psychosis, schizophrenia, bipolar affective disorder, or depression
- Understand spoken or written English
Further information:
Taking part in this study would involve meeting a member of the AWP Research & Development team either in person or by telephone or video call.
At this meeting, you would have the opportunity to ask questions about the study and have time to think about taking part.
If you consent to taking part, the next step requires the completion of a questionnaire with a researcher. This would involve personal questions about your environment, lifestyle, and health, including mental health.
There would be an expectation to provide a blood sample taken from the arm.
There would be further questions to complete within a week of the assessment, taking around 30 minutes.
NCMH are offering a £25 gift voucher to participants as a thank you.
AWP Research and Development Contacts:
This study will close on the 29th February 2024
The University of Manchester are conducting a research study to understand staff and service user views about using digital devices, such as a smartphone or wearable device, to help manage mental health.
The study team would like to understand service user opinions of this topic, as well as how people use digital devices.
The study will aim to survey at least 300 people with lived-experience of psychosis. The study team would like those taking part in the survey to have a wide range of experience using technology. This includes people that already use a smartphone or wearable device, and those that do not.
To take part in this study, people must:
- Be aged 18 or above
- Have a diagnosis or have treatment for psychosis, schizophrenia, or unusual distressing experiences (e.g. hearing voices or having usual beliefs)
- Be able to understand and speak English
Further information:
You will be asked some questions about your age, mental health and use of mental health services to confirm you can take part in the study.
If you are able to take part, you will be asked to complete a survey; either online or using a paper copy. This survey will ask about your views of digital devices, as well as how these can be used in mental healthcare.
The survey should take 20-30 minutes to complete. Survey responses are anonymous and there will be no way to identify the people that take part.
By taking part in this survey, you service users are eligible to be entered into a prize draw to win £50 (as vouchers, cash, or bank payment).
To read the participant information sheet and take part in the study, please click here.
AWP Research and Development contacts:
Harry Walker (harry
This study closes on the 1st May 2024
The STOP trial aims to investigate the use of a new treatment for the symptoms of paranoia. The treatment uses a mobile phone App aimed at reducing cognitive bias, meaning the way the brain simplifies information through the filters of personal experience. The trial will test whether the mobile phone App can help replace harmful and distressing paranoid thoughts with better alternatives.
To take part in this study, people must:
- Be age 18 or above
- Have clinically significant paranoid and persecutory symptoms that have continued for at least a month, regardless of diagnosis
- Have been stable on psychotropic medication for a minimum of 3 months
- Have no major physical illness or substance misuse issues (alcohol or drugs)
- Have an understanding of written and spoken English
- Have capacity to consent to take part in the trial
Further information:
You will be asked to use a mobile phone App once per week for either 6 or 12 weeks. This App can be downloaded onto your own smartphone or a smartphone that can be provided for the trial period.
You will be asked to complete an initial assessment with a researcher at the University of Bath. Following this assessment, the researcher will phone you either weekly or fortnightly for a short conversation. There will be follow-up assessments at 6, 12, 18 and 24 weeks after starting the trial. You can claim £20 for completing each follow-up assessment and a final assessment.
Taking part in this trial does not affect access to your current treatment. Taking part in this trial is voluntary and anyone can withdraw at any point.
More information about the STOP trial can be found here.
AWP Research and Development contacts:
Darren French (d
David Rudall (d
This study will close on the 30th June 2024
Background:
The CaFI Team are based at the University of Manchester and Greater Manchester Mental Health NHS Foundation Trust.
They are researching a talking therapy designed to meet the needs of African and Caribbean service users with psychosis and their families.
CaFI aims to work together with families with African and Caribbean heritage to help them learn about psychosis / schizophrenia and plan for positive change.
Half of the families that take part will receive talking therapy and half will receive their usual care.
The talking therapy will involve receiving 10, one-hour long sessions, over a 26 week period (as well as your usual care). These will take place online.
The talking therapy sessions aim to help by:
- Learning about psychosis, treatments, and support systems
- Supporting helpful communication with services and between family members
- Learning how to cope better within the family
- Supporting families to set goals and plan for positive change
Everyone who takes part in CaFI Trial will meet with a researcher three times during the study to go through questions about mental health, quality of life, and relationships.
To take part in this trial
Service users must:
- Have a diagnosis of schizophrenia or psychosis
- Be of Sub-Saharan African or Caribbean origin
- Have least 1 Sub-Saharan African or Caribbean parent or grandparent
- Be receiving treatment in community services, psychiatric inpatient services, or forensic services
- Be at least 14 years or older (if you are under 16, you must have your parent/guardian/carer’s consent to take part)
- Have an understanding of written and spoken English
- Have capacity to consent to take part in the trial
People would be unable to take part in this trial if they:
- Are currently receiving any form of family intervention
- Have substance misuse as a primary diagnosis
- Have an organic brain disorder or cognitive impairment
Family members / nominated Family Support Members (FSMs)
Family members or nominated Family Support Members (nFSMs) do not have to be of African or Caribbean origin. nFSMs can be a trusted individual, such as a friend or support worker.
Family members / nFSMs must:
- Understand English enough to complete questionnaires
- Be 14 years or older (parental/guardian consent needed if under 16 years old)
- Have capacity to provide informed consent
Additional Information:
CaFI Trial website: https://sites.manchester.ac.uk/cafi/
As a thank you for participating, both the service user and their family member (or nFSM) will receive £10 for completing questionnaires and interviews at all three time points (3 months, 6 months, and 12 months). This is £30 for the duration of the study for both.
Contact information:
If you have any questions or would like further information please contact a member of the AWP Research and Development team below.
AWP Research and Development contacts:
Mashal Asif – mashal
David Rudall – d
This study closes 31st March 2024
The University of Oxford Study team are interested in better understanding what helps and hinders physical activity for individuals who experience psychosis. This will help to develop better support for individuals wanting to be more physically active in the future.
To take part in this trial you must:
- Be aged 16 or older
- Are in contact with mental health services
- Have been given a diagnosis of non-affective psychosis (e.g. schizophrenia, schizoaffective disorder, delusional disorder or psychosis not otherwise specified)
Additional information:
Individuals will be asked to complete a number of questionnaires supported by someone from the Research and Development delivery team, which should take around 30-45 minutes to complete. These can be completed in person, online, on the phone, or via video call depending on individual preferences.
The questionnaires will ask for demographic information, current activity levels, thoughts about being physically active, and other thoughts, feelings and experiences individuals may have.
A small group of about 100 people will be asked to complete a small portion of the questionnaires one week later. This is optional.
Those who take part will be given £10 per questionnaire to thank them for their time.
AWP Research and Development contacts:
Harry Walker (harry
Monalisa Bora-White (monalisa
This study closes on the 1st January 2024
The University of Oxford Study team are interested in better understanding why people might get angry or become aggressive to better support people and improve treatments to reduce violence.
To take part in this study, people must:
- Be aged 16 or older
- Identify as male
- Are in contact with mental health services
- Have been given a diagnosis of psychosis
Individuals do not need to have had experiences with anger, aggression or violence to take part in this study – all experiences are equally helpful.
Further Information:
Individuals will be asked to complete a number of questionnaires supported by someone from the Research and Development delivery team, which should take around an hour to complete. These can be completed in person, online, on the phone, or via video call depending on your preference.
The questionnaires will ask for: demographic information, experiences of feeling angry, how individuals cope with anger, individual beliefs and feelings towards aggression and thoughts they may have about other people.
A small group of about 100 people will be asked to complete a small portion of the questionnaires one week later. This is optional.
AWP Research and Development contacts:
Monalisa Bora-White (Monalisa
This study will close on the 31st January 2024
Complex Emotional Needs
Some people in contact with mental health services experience emotional distress that is linked to long-standing difficulties in relationships with other people. This can affect their ability to form and maintain healthy relationships with other people. This can also affect mood and ability to manage difficult feelings.
Existing psychological approaches are helpful to people with complex emotional needs, but these can be long-term and delivered in groups. There can be long waiting lists for these groups and people can find it difficult to attend due to different reasons.
Structured Psychological Support (or SPS) is a short-term and less intense type of support for people with complex emotional needs. This study aims to find out if Structured Psychological Support (SPS) is effective.
In the SPS study, people taking part will be divided at random into two groups.
One group of people taking part will receive the SPS intervention. This intervention includes six to ten sessions of psychological support. These sessions will be delivered by a trained professional on a one-to-one basis. The sessions will focus on personal difficulties, as well as techniques to improve mental health and functioning.
The other group will receive treatment-as-usual, meaning that the available support is no different to that normally available to you. However, if you do not already have a personal safety or crisis plan, you will be invited to create one in an appointment with a trained mental health professional.
To take part in the SPS study, people must:
- Be aged 18 or over
- Be suggested for the study by a mental health professional who has assessed you as having complex emotional needs
- Not be receiving or on a waiting list to receive treatment for complex emotional needs
- Not have a psychotic mental health condition, such as schizophrenia
- Not have an organic mental health condition, such as dementia
- Be willing and able to provide informed consent to take part in the study
Further information:
Before the SPS study starts, you will be asked to a face-to-face appointment to give your consent to take part, and complete a brief questionnaire to check you can take part. If you are able to take part, you will be asked to complete a number of questionnaires.
These questionnaires ask about your mental and physical health, the way you feel about life and health, and your use of health services. The SPS study team would also like to ask about your social life and activity in the community. You will be offered a £10 voucher for completing the questionnaires.
After the start of the study, a researcher will check in with you at 3 months and 9 months by telephone call. Following 6 and 12 months into the study, you will be asked to attend face-to-face appointments, where you will be asked to repeat the same questionnaires as the start of the study. If you are unable to make a face-to-face appointment, then an online meeting would also be an option. Each time you complete the questionnaire you will offered a £20 voucher.
At the end of the study, the SPS study team might ask you to an interview about your experiences of the study. This interview is optional.
The SPS study is being coordinated by Imperial College London over seven NHS Trusts.
AWP Research and Development contact:
This study will close on the 8th February 2024
Dementia
The MySmile Study is a Randomised Control Trial (RCT) for adults with Alzheimer’s disease, looking at whether reducing periodontal infection (gum disease) slows the progression of cognitive impairment. Periodontal infection is mainly caused by inflammation of gums and surrounding bone.
The MySmile research group and others have found links between Alzheimer’s and gum disease. Gum disease occurs when certain bacteria thrive under the gum line causing inflammation and bleeding. There is good evidence these bacteria pass into the bloodstream and speed up, or cause development of other diseases (such as diabetes and heart disease).
The study will compare two groups of patients who have both early Alzheimer’s and gum disease. One group will continue to look after their teeth and attend their own dental practice as usual. The other group will receive a personalised mouth care plan with all treatment provided at Bristol Dental Hospital or an accredited General Dental Practice.
The study will last 18 months. Taking part will involve completing a number memory tests, having dental assessments, and providing saliva and blood samples at different time points over 18 months.
To take part in the study, people must:
- Be aged 60 and over
- Have a diagnosis of Alzheimer’s Disease of Mild Cognitive Impairment
- Be interested in improving your oral (gum) health
MySmile study team contact:
If you wish to discuss taking part in the MySmile study, you can contact the MySmile study team directly by telephone (07773 579130) or email (Nikki
AWP Research and Development contact:
Monalisa Bora-White (monalisa
This study closes on the 31st January 2024
Eating Disorders
EDGI is a project set up to explore risk factors in individuals who have experienced eating disorders, including anorexia nervosa, bulimia nervosa, binge-eating disorder or any other eating disorder at any time in their lives.
It aims to better understand the genetic and environmental links to eating disorders in order to improve treatments for current and future patients. EDGI is also part of the NIHR BioResource, which is a library of information about people’s health aiming to support research in both physical and mental health.
To take part in this study, people must:
- Be aged 16 and above
- Live in England
- Be currently experiencing or have experienced an eating disorder
The EGDI study process involves of four steps:
- Registering on the website edgiuk.org and reading the information sheet
- Providing consent using the online form (please put AWP as where you heard about the study)
- Completing a questionnaire
- Providing a saliva sample
AWP Research and Development contact:
This study will close on the 1st September 2024
General studies
The University of Bristol and Sheffield are interested in better understanding how to make mental health services work better together to improve mental health and reduce mental health inequalities.
To take part in this study, people must:
- Be aged 18 years or above
- For service users: Have accessed mental health services within Bristol or South Gloucestershire in the last 2 years
- For staff: Have worked within mental health services within Bristol or South Gloucestershire
Further Information:
Those who are interested will be invited to talk about their views of integrated health services in a group workshop, either in person at a venue in Bristol or online. This workshop will last approximately 2 hours.
Service users will be given £50 as a thank you for their time. For those who attend a face-to-face workshop, reasonable travel costs will be covered.
Study contact:
Katrina d’Apice
Email: katrina
Telephone: 0117 455 3759
This study will close on the 31st December 2023
Learning Disabilities
Art psychotherapy is used in the NHS to support people with mental health difficulties. However, more research is needed to find out if this therapy is helpful for people with learning disabilities in forensic and secure mental health services.
The SCHEMA team are looking to find out if interpersonal art psychotherapy can reduce experiences of aggression for adults in secure care with borderline to mild/moderate learning disability. They also want to find out whether art psychotherapy can reduce the distress that these patients experience from their symptoms.
To take part in this study, people must:
- Be aged 18 to 60
- Be an inpatient in an NHS secure hospital, unit, or service
- Have a learning disability or borderline intellectual functioning
- Be able to give informed consent
- Have support from their responsible clinician or team to participate
Further information:
SCHEMA is a randomised control trial, which means a computer will randomly decide if participants receive art psychotherapy straight away or if they will be put on a waitlist for art psychotherapy. This means the researchers can compare art psychotherapy to usual care to see if it helps people. All participants will receive 12 weeks of art psychotherapy by the end of the study.
Each art therapy session is an hour long, with one per week for a total of 12 sessions. In the sessions, individuals will be able to talk with a therapist and make artwork. They do not need to be good at art to do art therapy. Doing art during therapy can make it easier to communicate.
Everyone who takes part in the study will be asked to complete some questionnaires with a researcher about their mental and physical health. These will be done at the start of the study, once after four months, and once more after nine months.
Individuals will receive a £15 voucher after the first questionnaire, a £15 voucher after the questionnaire at four months, and a final £20 voucher after the questionnaire at nine months, totalling £50 for completing the study.
AWP Research and Development contacts:
David Rudall (d
Emily Avent (e
You can also contact the study team by emailing schema
This study will close on the 31st March 2024
Perinatal
The National Centre for Mental Health (NCMH) is heading an important research study called Maternal Wellbeing, Mental Health and Life Experiences.
This is an online survey that’s looking to understand more about how life experiences and COVID-19 have impacted on maternal wellbeing and mental health during the perinatal period.
We hope the findings will lead to new and improved ways of recognising and providing support in times of need.
The survey can be found here.
To take part in this study, people must:
- Be over 18-years-old
- Be pregnant or have given birth in the last 12 months
Individuals with or without a mental health diagnosis are welcome to complete the survey.
Participants will also be entered into a prize draw to win up to the value of £100 for their continued participation in the follow up maternal mental health surveys.
AWP Research and Development contacts:
Alexandra Young (alexandra
This study closes on the 31st March 2025
Physical and mental health
The DIAMONDS Trial is a Randomised Control Trial (RCT) looking at improving diabetes self-management for people with severe mental illness (SMI) by comparing using a 6-month programme with usual care.
The DIAMONDS trial aims to test a self-management intervention that can specifically help people with diabetes and severe mental illness to be healthier. The intervention has been developed in partnership with people with mental illness and diabetes, their family members/friends, and the healthcare staff who support them.
The trial will last for 12 months. Taking part will involve completing a number questionnaires, clinical assessments, physical health checks and providing a blood sample at an initial appointment, and then again at 6 and 12 months. Visits will either take place at Gloucester Health and Care NHS Foundation Trust or Somerset Partnership NHS Trust.
To take part in the study, people must:
- Be aged 18 and over
- Have a diagnosis of schizophrenia, bipolar disorder, schizoaffective disorder, psychosis or severe depression
- Have a diagnosis of type 2 diabetes
DIAMONDS study team contact:
Dr Grace O'Carroll, Trial Coordinator (Grace
Lucy Sheehan, Trial Coordinator (lucy
AWP Research and Development contact:
Teleri Dyer, Research Practitioner (teleri
This study closes on 31st May 2024
Staff (internal and external)
The University of Manchester are conducting a research study to understand staff and service user views about using digital devices, such as a smartphone or wearable device, to help manage mental health.
The study team would like to hear the opinions of healthcare professionals about this topic, as well as how digital health tools could be used in mental healthcare delivery.
The study will aim to survey at least 300 healthcare professionals who provide care for those with psychosis, schizophrenia or any other mental health problem with psychotic experiences (for example hallucinations or delusions). The study team would like those taking part in the survey to have a wide range of experience using technology. This includes people that already use a smartphone or wearable device, and those that do not.
To take part in this study, people must:
- Be aged 18 or above
- Be a healthcare professional who provides care for individuals diagnosed with psychosis, schizophrenia, or any other mental health issue which includes psychotic experiences (for example hallucinations or delusions)
Further information:
You will be asked some questions about your age, occupation, and the service you work in.
If you are able to take part, you will be asked to complete a survey; either online or using a paper copy. This survey will ask about your views of digital devices, as well as how these can be used in mental healthcare.
The survey should take 20-30 minutes to complete. Survey responses are anonymous and there will be no way to identify the people that take part.
By taking part in this survey, you service users are eligible to be entered into a prize draw to win £20 (as a voucher).
To read the participant information sheet and take part in the study, please click here.
AWP Research and Development contacts:
Harry Walker (harry
This study closes on the 1st May 2024
Participant in Research Experience Survey (PRES)
Click the button below to tell us about your experience of taking part in research.